A Danish risk assessment for withania somnifera, also called ashwagandha or Indian ginseng, shows health risks with the plant. The risk assessment cannot establish a safe lower limit for ashwagandha.
The risks of the plant have been discussed for a long time, and the Technical University of Denmark (DTU) has carried out several risk assessments of the plant in dietary supplements. The conclusion of the latest risk assessment is that the root or extract of the root, for example, can have a negative effect on thyroid hormones and on sex hormones. It has not been possible based on the available data to establish a lower safe dose. Germany makes a similar assessment of the plant.
A number of Swedish products with high levels of ashwagandha have recently been banned in Denmark, and thus the issue has become topical in Sweden. The Swedish Food Agency has therefore reviewed the Danish risk assessment and assessed that it can also be applied in Sweden. However, it is up to each municipality, as a control authority, to decide in individual cases.
Source: Dansk riskvärdering för ashwagandha kan användas i Sverige (livsmedelsverket.se)
It will be interesting to see how this evolves.
The risks of the plant have been discussed for a long time, and the Technical University of Denmark (DTU) has carried out several risk assessments of the plant in dietary supplements. The conclusion of the latest risk assessment is that the root or extract of the root, for example, can have a negative effect on thyroid hormones and on sex hormones. It has not been possible based on the available data to establish a lower safe dose. Germany makes a similar assessment of the plant.
A number of Swedish products with high levels of ashwagandha have recently been banned in Denmark, and thus the issue has become topical in Sweden. The Swedish Food Agency has therefore reviewed the Danish risk assessment and assessed that it can also be applied in Sweden. However, it is up to each municipality, as a control authority, to decide in individual cases.
Source: Dansk riskvärdering för ashwagandha kan användas i Sverige (livsmedelsverket.se)
It will be interesting to see how this evolves.